tenk.fyi

Artiva Biotherapeutics, Inc.

ARTVNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$0

100.0% YoY

Net Income

-$83.9M

28.3% YoY

EPS

$-3.43

41.0% YoY

Cash

$26.7M

33.6% YoY

FY 2025 · As of 2025-12-31